Africa’s first cell and gene therapy startup raises R29 million in landmark funding round
Altera Biosciences, Africa’s first dedicated cell and gene therapy startup, has secured R29 million in one of the largest pre-seed funding rounds in South African biotech history.
Biotech startup Altera lands R29m to pioneer Africa’s first universal donor cell platform
In a historic leap for biotech in Africa, Pretoria-based Altera Biosciences has secured R29 million in pre-seed funding to develop a universal donor cell platform aimed at revolutionising transplant medicine. The technology could enable off-the-shelf cell therapies to overcome one of medicine’s greatest challenges: donor–recipient matching – a problem particularly acute in Africa given its unmatched genetic diversity.
Altera Biosciences Bags $1.6M to Build ‘Off-the-Shelf’ Cells in Africa’s First Gene Therapy Play
In a sector where “groundbreaking” is the standard adjective, a South African company
